Validation pour Ingenuity294

vers la météo de la validation par utilisateur

Ingenuity294

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 15 - PMID ?

In primary SP peritoneal macrophages , ciglitazone causes little or no change in expression of SP NODE mRNA .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   +----------------------COMP:N-N(in)---------------------+                   |          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       +----------COMP:N-N(in)---------+                   |          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
COMP:N-N(in) (macrophage,expression)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 1

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   +----------------------COMP:N-N(in)---------------------+                   |          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       +----------COMP:N-N(in)---------+                   |          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
COMP:N-N(in) (macrophage,expression)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 2

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   +----------------------------COMP:N-N(of)---------------------------+       |          
               |                   +----------------------COMP:N-N(in)---------------------+           |       |          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       +----------------COMP:N-N(of)---------------+       |          
               |                   |                       +----------COMP:N-N(in)---------+           |       |          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
               |                   |                       |                   +------COMP:N-N(of)-----+       |          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
COMP:N-N(in) (macrophage,expression)
COMP:N-N(of) (macrophage,__SP__)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(of) (cause,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 3

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   +----------------------------COMP:N-N(of)---------------------------+       |          
               |                   +----------------------COMP:N-N(in)---------------------+           |       |          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       +----------------COMP:N-N(of)---------------+       |          
               |                   |                       +----------COMP:N-N(in)---------+           |       |          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
               |                   |                       |                   +------COMP:N-N(of)-----+       |          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
COMP:N-N(in) (macrophage,expression)
COMP:N-N(of) (macrophage,__SP__)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(of) (cause,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 4

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
       +-------MOD_ATT:N-ADJ-------+                       +----------COMP:N-N(in)---------+                   |          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------------SUBJ:V-N-----------+          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 5

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
                                   |                       +----------------COMP:N-N(of)---------------+       |          
                                   |                       +----------COMP:N-N(in)---------+           |       |          
       +-------MOD_ATT:N-ADJ-------+                       |                   +------------SUBJ:V-N-----------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------COMP:N-N(of)-----+       |          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(of) (cause,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 6

                                                           +--------------------COMP:V-N(In)-------------------+          
       +-------------------MOD_ATT:N-ADJ-------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      +------COMP:N-N(in)------+                   |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 7

                                                           +--------------------COMP:V-N(In)-------------------+          
       +-------------------MOD_ATT:N-ADJ-------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      +------COMP:N-N(in)------+                   |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 8

                                                           +--------------------COMP:V-N(In)-------------------+          
                                                           |      +------------------SUBJ:V-N------------------+          
                                                           |      +------------COMP:N-N(of)------------+       |          
       +-------------------MOD_ATT:N-ADJ-------------------+      |            +------------SUBJ:V-N-----------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------COMP:N-N(in)------+           |       |          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 9

                                                           +--------------------COMP:V-N(In)-------------------+          
                                                           |      +------------------SUBJ:V-N------------------+          
                                                           |      +------------COMP:N-N(of)------------+       |          
       +-------------------MOD_ATT:N-ADJ-------------------+      |            +------------SUBJ:V-N-----------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------COMP:N-N(in)------+           |       |          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 10

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
       +-------MOD_ATT:N-ADJ-------+                       +----------------------SUBJ:V-N---------------------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------------SUBJ:V-N-----------+          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 11

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
       +-------MOD_ATT:N-ADJ-------+                       |                   +------------SUBJ:V-N-----------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------COMP:N-N(of)-----+       |          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 12

       +-------------------MOD_ATT:N-ADJ-------------------+--------------------COMP:V-N(In)-------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------------------SUBJ:V-N------------------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------------SUBJ:V-N-----------+          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 13

       +-------------------MOD_ATT:N-ADJ-------------------+--------------------COMP:V-N(In)-------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------------------SUBJ:V-N------------------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------------SUBJ:V-N-----------+          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 14

                                                           +--------------------COMP:V-N(In)-------------------+          
       +-------------------MOD_ATT:N-ADJ-------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 15

                                                           +--------------------COMP:V-N(In)-------------------+          
       +-------------------MOD_ATT:N-ADJ-------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 16

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   +----------------------COMP:N-N(in)---------------------+                   |          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       +----------COMP:N-N(in)---------+                   |          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
COMP:N-N(in) (macrophage,expression)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 17

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   +----------------------COMP:N-N(in)---------------------+                   |          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       +----------COMP:N-N(in)---------+                   |          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
COMP:N-N(in) (macrophage,expression)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 18

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   +----------------------------COMP:N-N(of)---------------------------+       |          
               |                   +----------------------COMP:N-N(in)---------------------+           |       |          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       +----------------COMP:N-N(of)---------------+       |          
               |                   |                       +----------COMP:N-N(in)---------+           |       |          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
               |                   |                       |                   +------COMP:N-N(of)-----+       |          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
COMP:N-N(in) (macrophage,expression)
COMP:N-N(of) (macrophage,__SP__)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(of) (cause,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 19

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   +----------------------------COMP:N-N(of)---------------------------+       |          
               |                   +----------------------COMP:N-N(in)---------------------+           |       |          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       +----------------COMP:N-N(of)---------------+       |          
               |                   |                       +----------COMP:N-N(in)---------+           |       |          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
               |                   |                       |                   +------COMP:N-N(of)-----+       |          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
COMP:N-N(in) (macrophage,expression)
COMP:N-N(of) (macrophage,__SP__)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(of) (cause,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 20

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 21

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 22

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
               |                   |                       |                   +------COMP:N-N(of)-----+       |          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 23

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
               |                   |                       |                   +------COMP:N-N(of)-----+       |          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 24

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 25

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 26

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
               |                   |                       |                   +------COMP:N-N(of)-----+       |          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 27

               +------------------------------------------COMP:V-N(In)-----------------------------------------+          
               |                   +----------------------------------SUBJ:V-N---------------------------------+          
               |                   |                       +----------------------SUBJ:V-N---------------------+          
               |                   |                       |                   +------------SUBJ:V-N-----------+          
               |                   |                       |                   +------COMP:N-N(of)-----+       |          
       +MOD_ATT+        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (__SP__,primary)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 28

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
       +-------MOD_ATT:N-ADJ-------+                       +----------------------SUBJ:V-N---------------------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------------SUBJ:V-N-----------+          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 29

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
       +-------MOD_ATT:N-ADJ-------+                       |                   +------------SUBJ:V-N-----------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------COMP:N-N(of)-----+       |          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 30

       +-------------------MOD_ATT:N-ADJ-------------------+--------------------COMP:V-N(In)-------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------------------SUBJ:V-N------------------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------------SUBJ:V-N-----------+          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 31

       +-------------------MOD_ATT:N-ADJ-------------------+--------------------COMP:V-N(In)-------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------------------SUBJ:V-N------------------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------------SUBJ:V-N-----------+          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 32

                                                           +--------------------COMP:V-N(In)-------------------+          
       +-------------------MOD_ATT:N-ADJ-------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 33

                                                           +--------------------COMP:V-N(In)-------------------+          
       +-------------------MOD_ATT:N-ADJ-------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 34

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
       +-------MOD_ATT:N-ADJ-------+                       +----------COMP:N-N(in)---------+                   |          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------------SUBJ:V-N-----------+          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 35

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
                                   |                       +----------------COMP:N-N(of)---------------+       |          
                                   |                       +----------COMP:N-N(in)---------+           |       |          
       +-------MOD_ATT:N-ADJ-------+                       |                   +------------SUBJ:V-N-----------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------COMP:N-N(of)-----+       |          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(of) (cause,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 36

                                                           +--------------------COMP:V-N(In)-------------------+          
       +-------------------MOD_ATT:N-ADJ-------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      +------COMP:N-N(in)------+                   |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 37

                                                           +--------------------COMP:V-N(In)-------------------+          
       +-------------------MOD_ATT:N-ADJ-------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      +------COMP:N-N(in)------+                   |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 38

                                                           +--------------------COMP:V-N(In)-------------------+          
                                                           |      +------------------SUBJ:V-N------------------+          
                                                           |      +------------COMP:N-N(of)------------+       |          
       +-------------------MOD_ATT:N-ADJ-------------------+      |            +------------SUBJ:V-N-----------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------COMP:N-N(in)------+           |       |          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 39

                                                           +--------------------COMP:V-N(In)-------------------+          
                                                           |      +------------------SUBJ:V-N------------------+          
                                                           |      +------------COMP:N-N(of)------------+       |          
       +-------------------MOD_ATT:N-ADJ-------------------+      |            +------------SUBJ:V-N-----------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------COMP:N-N(in)------+           |       |          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 40

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
       +--------MOD_ATT:N-N--------+                       +----------COMP:N-N(in)---------+                   |          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------------SUBJ:V-N-----------+          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 41

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
                                   |                       +----------------COMP:N-N(of)---------------+       |          
                                   |                       +----------COMP:N-N(in)---------+           |       |          
       +--------MOD_ATT:N-N--------+                       |                   +------------SUBJ:V-N-----------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------COMP:N-N(of)-----+       |          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(of) (cause,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 42

                                                           +--------------------COMP:V-N(In)-------------------+          
       +--------------------MOD_ATT:N-N--------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      +------COMP:N-N(in)------+                   |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 43

                                                           +--------------------COMP:V-N(In)-------------------+          
       +--------------------MOD_ATT:N-N--------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      +------COMP:N-N(in)------+                   |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 44

                                                           +--------------------COMP:V-N(In)-------------------+          
                                                           |      +------------------SUBJ:V-N------------------+          
                                                           |      +------------COMP:N-N(of)------------+       |          
       +--------------------MOD_ATT:N-N--------------------+      |            +------------SUBJ:V-N-----------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------COMP:N-N(in)------+           |       |          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 45

                                                           +--------------------COMP:V-N(In)-------------------+          
                                                           |      +------------------SUBJ:V-N------------------+          
                                                           |      +------------COMP:N-N(of)------------+       |          
       +--------------------MOD_ATT:N-N--------------------+      |            +------------SUBJ:V-N-----------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------COMP:N-N(in)------+           |       |          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 46

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
       +--------MOD_ATT:N-N--------+                       +----------------------SUBJ:V-N---------------------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------------SUBJ:V-N-----------+          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 47

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
       +--------MOD_ATT:N-N--------+                       |                   +------------SUBJ:V-N-----------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------COMP:N-N(of)-----+       |          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 48

       +--------------------MOD_ATT:N-N--------------------+--------------------COMP:V-N(In)-------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------------------SUBJ:V-N------------------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------------SUBJ:V-N-----------+          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 49

       +--------------------MOD_ATT:N-N--------------------+--------------------COMP:V-N(In)-------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------------------SUBJ:V-N------------------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------------SUBJ:V-N-----------+          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 50

                                                           +--------------------COMP:V-N(In)-------------------+          
       +--------------------MOD_ATT:N-N--------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 51

                                                           +--------------------COMP:V-N(In)-------------------+          
       +--------------------MOD_ATT:N-N--------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 52

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
       +--------MOD_ATT:N-N--------+                       +----------------------SUBJ:V-N---------------------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------------SUBJ:V-N-----------+          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 53

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
       +--------MOD_ATT:N-N--------+                       |                   +------------SUBJ:V-N-----------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------COMP:N-N(of)-----+       |          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 54

       +--------------------MOD_ATT:N-N--------------------+--------------------COMP:V-N(In)-------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------------------SUBJ:V-N------------------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------------SUBJ:V-N-----------+          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 55

       +--------------------MOD_ATT:N-N--------------------+--------------------COMP:V-N(In)-------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------------------SUBJ:V-N------------------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------------SUBJ:V-N-----------+          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 56

                                                           +--------------------COMP:V-N(In)-------------------+          
       +--------------------MOD_ATT:N-N--------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 57

                                                           +--------------------COMP:V-N(In)-------------------+          
       +--------------------MOD_ATT:N-N--------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 58

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
       +--------MOD_ATT:N-N--------+                       +----------COMP:N-N(in)---------+                   |          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------------SUBJ:V-N-----------+          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 59

                                   +--------------------------------COMP:V-N(In)-------------------------------+          
                                   |                       +----------------------SUBJ:V-N---------------------+          
                                   |                       +----------------COMP:N-N(of)---------------+       |          
                                   |                       +----------COMP:N-N(in)---------+           |       |          
       +--------MOD_ATT:N-N--------+                       |                   +------------SUBJ:V-N-----------+          
       |       +---MOD_ATT:N-ADJ---+                       |                   +------COMP:N-N(of)-----+       |          
       |       |        +MOD_ATT:N-+             +MOD_ATT:N+                   +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |          |             |         |                   |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (macrophage,primary)
MOD_ATT:N-ADJ (macrophage,__SP__)
MOD_ATT:N-ADJ (macrophage,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (cause,expression)
COMP:N-N(of) (cause,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,macrophage)
SUBJ:V-N (__NODE__,cause)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 60

                                                           +--------------------COMP:V-N(In)-------------------+          
       +--------------------MOD_ATT:N-N--------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      +------COMP:N-N(in)------+                   |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 61

                                                           +--------------------COMP:V-N(In)-------------------+          
       +--------------------MOD_ATT:N-N--------------------+      +------------------SUBJ:V-N------------------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      |            +------------SUBJ:V-N-----------+          
       |       |        +-----------MOD_ATT:N-ADJ----------+      +------COMP:N-N(in)------+                   |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+COMP:N-N(of+       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (expression,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 62

                                                           +--------------------COMP:V-N(In)-------------------+          
                                                           |      +------------------SUBJ:V-N------------------+          
                                                           |      +------------COMP:N-N(of)------------+       |          
       +--------------------MOD_ATT:N-N--------------------+      |            +------------SUBJ:V-N-----------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------COMP:N-N(in)------+           |       |          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)

Analyse 63

                                                           +--------------------COMP:V-N(In)-------------------+          
                                                           |      +------------------SUBJ:V-N------------------+          
                                                           |      +------------COMP:N-N(of)------------+       |          
       +--------------------MOD_ATT:N-N--------------------+      |            +------------SUBJ:V-N-----------+          
       |       +---------------MOD_ATT:N-ADJ---------------+      +------COMP:N-N(in)------+           |       |          
       |       |        +-----------MOD_ATT:N-ADJ----------+      |            +------COMP:N-N(of)-----+       |          
       |       |        |                        +MOD_ATT:N+      |            +COMP:N-N(in+           |       +OBJ:V-+   
       |       |        |                        |         |      |            |           |           |       |      |   
 In primary __SP__ peritoneal macrophages , ciglitazone causes little or no change in expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (cause,primary)
MOD_ATT:N-ADJ (cause,__SP__)
MOD_ATT:N-ADJ (cause,peritoneal)
MOD_ATT:N-ADJ (cause,ciglitazone)
COMP:N-N(in) (little,expression)
COMP:N-N(of) (little,__SP__)
COMP:N-N(in) (change,expression)
COMP:N-N(of) (change,__SP__)
COMP:V-N(In) (__NODE__,cause)
SUBJ:V-N (__NODE__,little)
SUBJ:V-N (__NODE__,change)
OBJ:V-N (__NODE__,mRNA)